1 Wong N, "tocellular carcinoma by spectral karyotyping" 32 : 1060-1068, 2000
2 Singer-Sam J, "X chromosome inactivation and DNA methylation" 64 : 358-384, 1993
3 Barlow DP, "The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus" 349 : 84-87, 1991
4 Liang G, "The gene for a novel transmembrane protein containing epidermal growth 14 정운복∙김순영∙전소영 외 6인 factor and follistatin domains is frequently hypermethylated in human tumor cells" 60 : 4907-4912, 2000
5 Kanai Y, "The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas" 71 : 355-359, 1997
6 Glynne-Jones E, "TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence" 94 : 178-184, 2001
7 Herman JG, "Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma" 91 : 9700-9704, 1994
8 Yoshiura K, "Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas" 92 : 7416-7419, 1995
9 Endo C, "Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung" 78 : 612-615, 1998
10 Sambrook J, "Molecular Cloning: A laboratory manual. 3rd" Cold Spring Harbor 6.1-6.11, 2001
1 Wong N, "tocellular carcinoma by spectral karyotyping" 32 : 1060-1068, 2000
2 Singer-Sam J, "X chromosome inactivation and DNA methylation" 64 : 358-384, 1993
3 Barlow DP, "The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus" 349 : 84-87, 1991
4 Liang G, "The gene for a novel transmembrane protein containing epidermal growth 14 정운복∙김순영∙전소영 외 6인 factor and follistatin domains is frequently hypermethylated in human tumor cells" 60 : 4907-4912, 2000
5 Kanai Y, "The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas" 71 : 355-359, 1997
6 Glynne-Jones E, "TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence" 94 : 178-184, 2001
7 Herman JG, "Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma" 91 : 9700-9704, 1994
8 Yoshiura K, "Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas" 92 : 7416-7419, 1995
9 Endo C, "Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung" 78 : 612-615, 1998
10 Sambrook J, "Molecular Cloning: A laboratory manual. 3rd" Cold Spring Harbor 6.1-6.11, 2001
11 Herman JG, "Methylation- specific PCR: a novel PCR assay for methylation status of CpG islands" 93 : 9821-9826, 1996
12 Ottaviano YL, "Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells" 54 : 2552-2555, 1994
13 Ransom DT, "Loss of heterozygosity on chromosome 2q: possibly a poor prognostic factor in head and neck cancer" 20 : 404-410, 1998
14 Shiraishi M, "Isolation of DNA fragments associated with methylated CpG islands in human adenocarcinomas of the lung using a methylated DNA binding column and denaturing gradient gel electrophoresis" 96 : 2913-2918, 1999
15 Peinado MA, "Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction" 89 : 10065-10069, 1992
16 Schmutte C, "Involvement of DNA methylation in human carcinogenesis" 379 : 377-388, 1998
17 Liew CT, "High frequency of p16INK4A gene alterations in hepatocellular carcinoma" 18 : 789-795, 1999
18 Young J, "HPP1: a transmembrane protein- encoding gene commonly methylated in colorectal polyps and cancers" 98 : 265-270, 2001
19 Welsh J, "Fingerprinting genomes using PCR with arbitrary primers" 18 : 7213-7218, 1990
20 Lee WH, "Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis" 91 : 11733-11737, 1994
21 Bird AP, "CpG-rich islands and the function of DNA methylation" 321 : 209-213, 1986
22 Moiseeva EP, "Characterisation of the promoter which regulates expression of a phosphoglucomutase-related protein, a component of the dystrophin/utrophin cytoskeleton predominantly expressed in smooth muscle" 248 : 634-643, 1997